In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.
The muralytic enzyme mutanolysin can act in vivo to eliminate chronic erosive arthritis induced in rats by polymers of peptidoglycan-polysaccharide isolated from group A streptococci (PG-APS). The amounts of PG-APS in the livers and spleens of rats treated with mutanolysin were significantly reduced compared with the amounts in control rats treated with phosphate-buffered saline. However, the amounts of PG-APS in the limbs of mutanolysin- and phosphate-buffered saline-treated rats were comparable. PG-APS polymers extracted from the livers, spleens, and limbs of mutanolysin-treated rats were extensively degraded, whereas PG-APS extracted from phosphate-buffered saline-treated rats had a high molecular weight. We propose that mutanolysin abrogates arthritis in rats by degrading PG-APS polymers to a size which is no longer able to induce chronic erosive arthritis, even though the polymers are still present in the limbs.
D000818:Animals; D001168:Arthritis / Q000517:prevention & control*; D001169:Arthritis, Experimental / Q000382:microbiology / Q000517:prevention & control*; D002473:Cell Wall / Q000378:metabolism*; D004487:Edema / Q000382:microbiology; D010450:Endopeptidases / Q000378:metabolism*; D005121:Extremities / Q000378:metabolism; D005260:Female; D008099:Liver / Q000378:metabolism; D008970:Molecular Weight; D010457:Peptidoglycan / Q000378:metabolism*; D011135:Polysaccharides, Bacterial / Q000378:metabolism*; D051381:Rats; D011917:Rats, Inbred Lew; D013154:Spleen / Q000378:metabolism
D010457:Peptidoglycan; D011135:Polysaccharides, Bacterial; D010450:Endopeptidases; C021816:mutanolysin